- Access simple and animated guided instructions
- Share your COVID-19 test results
- Access historical results for you
- Available on Apple iPhones with iOS 13 or higher and Android smartphones with Android 9 or higher
- This test is authorized for non-prescriptive home-use with self-collection for individuals aged 14 and older
- The test is acceptable for children aged 2-14, with the assistance of an adult
- The intended use of this test is for testing individuals within the first 6 days of symptom onset when tested at least twice over three days with at least 48 hours between tests, and for individuals without symptoms or other epidemiological reasons to suspect COVID-19, when tested at least three times over five days with at least 48 hours between tests.
Each pack contains:
- Printed instructions
- Test strips
- Nasal swabs
- Reagent solution tubes
- Tube holder
Latest updates
- Department of Health and Human Services press release
- Centers for Medicare & Medicaid Services FAQs
- Department of Labor FAQs
- Medicare coverage for COVID-19
Help stop the spread
Share your test results with public health authorities. Prevent the spread of COVID-19 and support contact-tracing efforts by reporting your results.
QuickVue At-Home OTC COVID-19 Test user instructions video
See how easy it is to use the QuickVue At-Home OTC COVID-19 Test and generate your results in just 10 minutes. Watch the video.
Video transcript (English)
Video transcript (Spanish)
The QuickVue At-Home OTC COVID-19 Test is fast, simple and designed to be used in the comfort of your home. This easy-to-use test requires a nasal swab sample to determine a positive or negative result for COVID-19. The testing procedure is simple and first, swirl the swab in a tube of reagent solution, then remove it. Next, insert a test strip into the solution. After 10 minutes, remove the test strip from the tube to confirm the results.
It is best practice to read the instructions prior to starting the test as it is important to follow the instructions to ensure an accurate result. For a quick overview, watch our test demonstration video above.
Healthcare Provider Instructions for Use (English)
Healthcare Provider Instructions for Use (Spanish)
For any product-related questions, view our FAQs
Meet QVue
Testing without stressing with the QuickVue companion app. Make your testing experience easier than ever. Learn more.
You are about to leave the QuidelOrtho website for a third-party site. Links which take you outside of the QuidelOrtho website are not under QuidelOrtho’s control, and QuidelOrtho is not responsible for any content or links contained therein. QuidelOrtho is providing these links to you only as a convenience, and such provision does not imply an endorsement by QuidelOrtho of any linked site. Any information you provide to a third-party site will be governed by the third-party’s website Terms of Use, including those related to confidentiality, data privacy and security.
For questions, product updates, news and more, contact us.
Our QuickVue At-Home OTC COVID-19 Test has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) under the new name – QuickVue COVID-19 Test, and will be available in late 2024.
Please note that the following information applies exclusively to the EUA (Emergency Use Authorization) products.
The QuickVue At-Home OTC COVID-19 Test is a lateral flow immunoassay device intended for the qualitative detection of nucleocapsid protein antigen from SARS-CoV-2.
This test is authorized for non-prescription home use with self-collected direct anterior nasal (nares) swab samples from individuals aged 14 years or older or adult-collected anterior nasal (nares) swab samples from individuals aged two years or older. This test is authorized for individuals with symptoms of COVID-19 within the first six days of symptom onset when tested at least twice over three days with at least 48 hours between tests, and for individuals without symptoms or other epidemiological reasons to suspect COVID-19, when tested at least three times over five days with at least 48 hours between tests. The QuickVue At-Home OTC COVID-19 Test does not differentiate between SARS-CoV and SARS-CoV-2.
*In the U.S., this product has not been FDA cleared or approved but has been authorized by FDA under an Emergency Use Authorization. This product has been authorized only for the detection of proteins from SARS-CoV-2, not for any other viruses or pathogens. The emergency use of this product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. § 360bbb-3(b)(1), unless the declaration is terminated or authorization is revoked sooner.